Drug Trial Radar · NCT00358215
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Last checked: Nov 20, 2026Latest source record: Nov 8, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,278
Actual
Start
Jun 1, 2006
Primary completion
Oct 11, 2012
Study completion Oct 11, 2012
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Jul 31, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to determine the efficacy of treatment of anemia with darbepoetin alfa compared to placebo on the composite of time to death from any cause or first hospital admission for worsening heart failure in patients with symptomatic left ventricular systolic dysfunction and anemia.
Conditions
- Heart Failure
- Anemia
- Cardiovascular Disease
- Ventricular Dysfunction
- Congestive Heart Failure
Interventions
Darbepoetin alfaDrug
Administered by subcutaneous injection
PlaceboDrug
Placebo subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to All Cause Death or First Hospitalization for Worsening Heart FailureTime frame: From randomization to the end of study; maximum time on study was 73 months
Locations
754 sites in 36 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama
Research Site
Birmingham, Alabama
Research Site
Huntsville, Alabama
Research Site
Mobile, Alabama
Research Site
Gilbert, Arizona
Research Site
Mesa, Arizona
Research Site
Scottsdale, Arizona
Research Site
Tucson, Arizona
Research Site
Little Rock, Arkansas
Research Site
Little Rock, Arkansas
Research Site
Anaheim, California
Research Site
Buena Park, California
Research Site
Corona, California
Research Site
Culver City, California
Research Site
Downey, California
Research Site
La Jolla, California
Research Site
Lancaster, California
Research Site
Larkspur, California
Research Site
Loma Linda, California
Research Site
Long Beach, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Modesto, California
Research Site
Oakland, California
Research Site
Pasadena, California
Research Site
Redondo Beach, California
Research Site
Sacramento, California
Research Site
Sacramento, California
Research Site
San Diego, California
Research Site
San Francisco, California
Research Site
San Francisco, California
Research Site
Santa Monica, California
Research Site
Santa Rosa, California
Research Site
Sylmar, California
Research Site
Walnut Creek, California
Research Site
Westlake Village, California
Research Site
Aurora, Colorado
Showing 40 of 754 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.